Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling.

Herzaft-LeRoy J, Xhignesse M, Gaboury I.

J Vis Exp. 2019 Feb 5;(144). doi: 10.3791/58740. Erratum in: J Vis Exp. 2019 Mar 6;(145):.

PMID:
30799839
2.

Strategies identified by program directors to improve adoption of the CanMEDS framework.

Gaboury I, Ouellet K, Xhignesse M, St-Onge C.

Can Med Educ J. 2018 Nov 12;9(4):e26-e34. eCollection 2018 Nov.

3.

Efficacy of an Osteopathic Treatment Coupled With Lactation Consultations for Infants' Biomechanical Sucking Difficulties.

Herzhaft-Le Roy J, Xhignesse M, Gaboury I.

J Hum Lact. 2017 Feb;33(1):165-172. doi: 10.1177/0890334416679620. Epub 2016 Dec 27.

PMID:
28027445
4.

Complementary and alternative medicine: Do physicians believe they can meet the requirements of the Collège des médecins du Québec?

Gaboury I, Johnson N, Robin C, Luc M, O'Connor D, Patenaude J, Pélissier-Simard L, Xhignesse M.

Can Fam Physician. 2016 Dec;62(12):e772-e775.

5.

Médecines alternatives et complémentaires: Les médecins se considèrent-ils en mesure de répondre aux exigences du Collège des médecins du Québec?

Gaboury I, Johnson N, Robin C, Luc M, O'Connor D, Patenaude J, Pélissier-Simard L, Xhignesse M.

Can Fam Physician. 2016 Dec;62(12):e767-e771. French. No abstract available.

PMID:
27965353
Free PMC Article
6.

Erratum to: Impact of an integrated obesity management system on patient's care - research protocol.

Baillargeon JP, St-Cyr-Tribble D, Xhignesse M, Grant A, Brown C, Poder TG, Langlois MF.

BMC Obes. 2016 Apr 29;3:23. doi: 10.1186/s40608-016-0101-9. eCollection 2016.

7.

Age-related decline and diagnostic performance of more and less prevalent clinical cases.

St-Onge C, Landry M, Xhignesse M, Voyer G, Tremblay-Lavoie S, Mamede S, Schmidt H, Rikers R.

Adv Health Sci Educ Theory Pract. 2016 Aug;21(3):561-70. doi: 10.1007/s10459-015-9651-8. Epub 2015 Nov 19.

PMID:
26584578
8.

Impact of an integrated obesity management system on patient's care - research protocol.

Baillargeon JP, St-Cyr-Tribble D, Xhignesse M, Grant A, Brown C, Langlois MF.

BMC Obes. 2014 Sep 3;1:19. doi: 10.1186/s40608-014-0019-z. eCollection 2014. Erratum in: BMC Obes. 2016;3:23.

9.

[Episodes of care: a concept in public health].

Gentil L, Vanasse A, Xhignesse M.

Cien Saude Colet. 2013 Jan;18(1):138-44. Review. Portuguese.

10.

[The ambulatory care of the acute myocardial infarction in Quebec: description, classification and typology].

Gentil L, Vanasse A, Xhignesse M, Courteau J, Bérubé S.

Ann Cardiol Angeiol (Paris). 2011 Aug;60(4):183-8. doi: 10.1016/j.ancard.2011.04.001. Epub 2011 May 12. French.

PMID:
21658674
11.

Severe injury mechanisms in two paediatric trauma centres: Determination of prevention priorities.

Cyr C, Xhignesse M, Lacroix J.

Paediatr Child Health. 2008 Mar;13(3):165-70.

12.

Empowerment interventions, knowledge translation and exchange: perspectives of home care professionals, clients and caregivers.

St-Cyr Tribble D, Gallagher F, Bell L, Caron C, Godbout P, Leblanc J, Morin P, Xhignesse M, Voyer L, Couture M.

BMC Health Serv Res. 2008 Aug 20;8:177. doi: 10.1186/1472-6963-8-177.

13.

[Management of thyroid dysfunction by primary care physicians of the Province of Quebec: a transversal study].

Gagnon F, Lareau-Trudel E, Bachand MP, Hamel C, Lapointe V, Dubois MF, Xhignesse M, Langlois MF.

Ann Endocrinol (Paris). 2008 Jun;69(3):210-7. doi: 10.1016/j.ando.2008.01.005. Epub 2008 Apr 11. French.

PMID:
18405877
14.

Evaluation of clinical innovation: a gray zone in the ethics of modern clinical practice?

Patenaude J, Grant AM, Xhignesse M, Leblanc F, Courteau J.

J Gen Intern Med. 2008 Jan;23 Suppl 1:27-31. doi: 10.1007/s11606-007-0410-2.

15.
16.

Integrated obesity care management system -implementation and research protocol.

Baillargeon JP, Carpentier A, Donovan D, Fortin M, Grant A, Simoneau-Roy J, St-Cyr-Tribble D, Xhignesse M, Langlois MF.

BMC Health Serv Res. 2007 Oct 10;7:163.

17.

Re-engineering cardiac rehabilitation programmes: considering the patient's point of view.

Pâquet M, Bolduc N, Xhignesse M, Vanasse A.

J Adv Nurs. 2005 Sep;51(6):567-76.

PMID:
16129007
18.

Training fourth-year medical students in critical invasive skills improves subsequent patient safety.

Martin M, Scalabrini B, Rioux A, Xhignesse MA.

Am Surg. 2003 May;69(5):437-40.

PMID:
12769219
19.

Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension.

Brassard P, Bourgault C, Brophy J, Kezouh A, Rainville B, Xhignesse M, Suissa S.

Am Heart J. 2003 May;145(5):E20.

PMID:
12766754
20.

Family history and the risk of coronary heart disease: comparing predictive models.

Ciampi A, Courteau J, Niyonsenga T, Xhignesse M, Lussier-Cacan S, Roy M.

Eur J Epidemiol. 2001;17(7):609-20.

PMID:
12086074
21.

Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype.

Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Sing CF.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):824-31.

PMID:
12006397
22.

Enhancing prevention in primary care: are interventions targeted towards consumers' and providers' perceived needs?

Beaulieu MD, Talbot Y, Jadad AR, Xhignesse M.

Health Expect. 2000 Dec;3(4):253-262.

23.

Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.

Xhignesse M, Laplante P, Niyonsenga T, Courteau J, Grant AM.

Can J Cardiol. 2000 Jul;16(7):879-85.

PMID:
10934306
24.

Impact of age and body size on inter-individual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotype.

Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Connelly PW, Sing CF.

Clin Genet. 2000 Jan;57(1):35-47.

25.

Sources of variation in plasma lipid and lipoprotein traits in a sample selected for health.

Lussier-Cacan S, Xhignesse M, Kessling AM, Davignon J, Sing CF.

Am J Epidemiol. 1999 Dec 1;150(11):1229-37.

PMID:
10588084
26.

Antiplatelet and lipid-lowering therapies for the secondary prevention of cardiovascular disease: are we doing enough?

Xhignesse M, Laplante P, Grant AM, Niyonsenga T, Delisle E, Vanasse N, Bernier R.

Can J Cardiol. 1999 Feb;15(2):185-9. Review.

PMID:
10079778
27.

Informatics methodologies for evaluation research in the practice setting.

Grant A, Buteau M, Richards Y, Delisle E, Laplante P, Niyonsenga T, Xhignesse M.

Methods Inf Med. 1998 Jun;37(2):178-81.

PMID:
9656661
28.

Cardiovascular disease. Physician attitudes toward prevention and treatment.

Grant AM, Niyonsenga T, Dion I, Delisle E, Xhignesse M, Bernier R.

Can Fam Physician. 1998 Apr;44:780-7.

29.

[Treatment patterns of hypertension in 1996. Data from the Quebec Family Practice, University of Sherbrooke registry].

Laplante P, Niyonsenga T, Delisle E, Vanasse N, Vanasse A, Grant AM, Xhignesse M.

Can Fam Physician. 1998 Feb;44:306-12. French.

30.

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.

Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr.

Am J Clin Nutr. 1996 Oct;64(4):587-93.

PMID:
8839504
31.

[Focus on smoking].

Gagné M, Gervais A, Juneau M, Laforte R, Lemoine C, Ostiguy G, Perreault D, Robitaille M, Taillefer J, Xhignesse M.

Union Med Can. 1994 Jan;123(1):6-8, 11-3. French. No abstract available.

PMID:
8109067
32.
33.

Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.

Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A.

Metabolism. 1991 Aug;40(8):849-54.

PMID:
1907348
34.

Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health.

Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J.

Arterioscler Thromb. 1991 Jul-Aug;11(4):1100-10.

PMID:
2065031
35.

Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects.

Mailly F, Xu CF, Xhignesse M, Lussier-Cacan S, Talmud PJ, Davignon J, Humphries SE, Nestruck AC.

J Lipid Res. 1991 Apr;32(4):613-20.

36.

Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia.

Dallongeville J, Roy M, Leboeuf N, Xhignesse M, Davignon J, Lussier-Cacan S.

Arterioscler Thromb. 1991 Mar-Apr;11(2):272-8.

PMID:
1998645
37.

Influence of a triphasic oral contraceptive preparation on plasma lipids and lipoproteins.

Lussier-Cacan S, Nestruck AC, Arslanian H, Xhignesse M, Davignon J, Kafrissen ME, Chapdelaine A.

Fertil Steril. 1990 Jan;53(1):28-34.

PMID:
2295346
38.

Eruptive and tubero-eruptive xanthomas of the skin arising on sites of prior injury. Two case reports.

Roederer G, Xhignesse M, Davignon J.

JAMA. 1988 Sep 2;260(9):1282-3. Erratum in: JAMA 1989 Mar 3;261(9):1280.

PMID:
3165471
39.

Identification of the patient at risk in the physician's office and drug management of dyslipoproteinemia.

Davignon J, Xhignesse M, Roederer G.

Can J Cardiol. 1988 Jul;4 Suppl A:36A-47A. Review.

PMID:
3052739

Supplemental Content

Loading ...
Support Center